| Change Notification | Applies to: * | Date | ||||||
|---|---|---|---|---|---|---|---|---|
| BM-DSG | CB-DSG | GDRI | TD-DSG | TL-DSG | WB-DSG | Red Book | ||
| No. 33 - 2025 France and Italy |
⬤ | 13.10.25 | ||||||
| No. 32 - 2025 Sexually Transmitted Disease |
⬤ | ⬤ | ⬤ | ⬤ | 13.10.25 | |||
| No. 31 - 2025 Tropical Viruses |
⬤ | 13.10.25 | ||||||
| No. 30 - 2025 Hepatitis A |
⬤ | ⬤ | 13.10.25 | |||||
| No. 29 - 2025 Accept and PCOS |
⬤ | 28.08.25 | ||||||
| No. 28 - 2025 Hepatitis C |
⬤ | 28.08.25 | ||||||
| No. 27 - 2025 Deferral after HAV, HBV and JEV vaccines |
⬤ | 28.08.25 | ||||||
| No. 26 - 2025 Weight Loss Medication |
⬤ | 28.08.25 | ||||||
| No. 25 - 2025 Red Cells and Plasma, Leucocyte Depleted |
⬤ | 07.08.25 | ||||||
| No. 24 - 2025 Platelets, Apheresis, in Additive Solution and Plasma, Leucocyte Depleted |
⬤ | 24.07.25 | ||||||
| No. 23 - 2025 Dried Plasma, Leucocyte Depleted |
⬤ | 24.07.25 | ||||||
| No. 22 - 2025 Injectable PrEP for HIV Prevention |
⬤ | ⬤ | ⬤ | ⬤ | 13.10.25 | |||
| No. 21 - 2025 Transgender and Non-Binary Individuals |
⬤ | ⬤ | 13.10.25 | |||||
| No. 20 - 2025 Chronic Fatigue Syndrome |
⬤ | ⬤ | 13.10.25 | |||||
| No. 19 - 2025 Infertility |
⬤ | ⬤ | 13.10.25 | |||||
| No. 18 - 2025 Hormone Replacement and Sex Hormone Therapy |
⬤ | ⬤ | 13.10.25 | |||||
| No. 17 - 2025 Kidney Disease |
⬤ | 13.10.25 | ||||||
| No. 16 - 2025 Eye Disease |
⬤ | 13.10.25 | ||||||
| No. 14 - 2025 Interpreters |
⬤ | ⬤ | 18.07.25 | |||||
| No. 13 - 2025 Injectable PrEP for HIV Prevention |
⬤ | 18.07.25 | ||||||
| No. 12 - 2025 Removal of Malaria Risk |
⬤ | 18.07.25 | ||||||
| No. 11 - 2025 Chapter 9.3 and Annexe 1 |
⬤ | 23.05.25 | ||||||
| No. 10 - 2025 Autologous Blood Donation |
⬤ | 30.04.25 | ||||||
| No. 09 - 2025 Table of Immunisation |
⬤ | ⬤ | ⬤ | ⬤ | ⬤ | 30.04.25 | ||
| No. 08 - 2025 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
⬤ | 30.04.25 | ||||||
| No. 07 - 2025 Memorial Tattoos |
⬤ | 30.04.25 | ||||||
| No. 06 - 2025 Endoscopy |
⬤ | 30.04.25 | ||||||
| No. 05 - 2025 Updates in the GDRI |
⬤ | 30.04.25 | ||||||
| No. 04 - 2025 Clinical supervision at donor sessions |
⬤ | 28.02.25 | ||||||
| No. 03 - 2025 Hepatitis C testing of donors transfused before 1996 (IBI update) |
⬤ | 17.02.25 | ||||||
| No. 02 - 2025 Human Plasma for Fractionation, Cryoprecipitate Depleted, LD |
⬤ | 24.01.25 | ||||||
| No. 01 - 2025 Removal of Dengue risk in Italy |
⬤ | 17.01.25 | ||||||
(*)
BM-DSG - Bone Marrow and Peripheral Blood Stem Cell Donor Selection Guidelines
CB-DSG - Cord Blood Donor Selection Guidelines
GDRI - Geographical Disease Risk Index
TD-DSG - Tissue (Deceased) Donor Selection Guidelines
TL-DSG - Tissue (Live) Donor Selection Guidelines
WB-DSG - Whole Blood and Components Donor Selection Guidelines
Red Book - Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK